Dual-aptamer-activated RCA-MOF synergistic platform for visual detection of leukemia-derived exosomes
Analytica Chimica Acta · 2026
DOI: 10.1016/j.aca.2026.346094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Ying Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, PR China. Hauptthemen laut MEDLINE: Exosomes, Aptamers, Nucleotide, Leukemia, Myeloid, Acute, Metal-Organic Frameworks. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Affiliated Hospital of Guizhou Medical University, Health Commission of Guizhou Province.
Abstract (Originalsprache)
The sensitive, point-of-care detection of acute myeloid leukemia (AML)-derived exosomes is essential for non-invasive diagnosis and therapy monitoring, but remains technically challenging. Here we report a colorimetric biosensor based on a dual -aptamer-initiated catalytic cascade, where simultaneous recognition of exosomal markers CD63 and PTK7 by engineered aptamers triggers an in situ rolling circle amplification (RCA) reaction. The resulting RCA product templates the assembly of a metal-organic framework (MOF) nanozyme, which acts as an efficient peroxidase mimic to generate a colorimetric readout. This integrated "recognition -amplification-transduction" nanoarchitecture achieves a detection limit of 0.1 ng/mL for PTK7-positive exosomes and successfully discriminates patient serum samples from healthy controls as well as AML-bearing mouse models from healthy mice, with consistent results obtained via UV-vis spectroscopy, visual colorimetry, and smartphone-based grayscale analysis. By synergizing nucleic acid nanotechnology with nanozyme catalysis, this work provides a rapid, equipment-free visual platform for exosome-based liquid biopsy in AML management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, PR China.
- Department of Cell Biology and Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guian New District, Guiyang, 561113, PR China.
- Research Center for Basic Sciences of Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guian New District, Guiyang, 561113, PR China.
- Department of Pediatrics, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, PR China. Electronic address: 469389553@qq.com.
- Department of Cell Biology and Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guian New District, Guiyang, 561113, PR China. Electronic address: wenxjgy@163.com.
- Department of Cell Biology and Molecular Medicine, School of Basic Medical Sciences, Guizhou Medical University, Guian New District, Guiyang, 561113, PR China; Engineering Research Center for Molecular Medicine, Key Lab…
Förderung
- National Natural Science Foundation of China
- Affiliated Hospital of Guizhou Medical University
- Health Commission of Guizhou Province
Zitieren
APA
Shen, Y., Xiao, Y., Liu, L., Zhai, S., Mu, R., Chen, J., Yang, X., Wen, X., Zhang, C., & Shi, H. (2026). Dual-aptamer-activated RCA-MOF synergistic platform for visual detection of leukemia-derived exosomes. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2026.346094
Vancouver
Shen Y, Xiao Y, Liu L, Zhai S, Mu R, Chen J, et al. Dual-aptamer-activated RCA-MOF synergistic platform for visual detection of leukemia-derived exosomes. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2026.346094
BibTeX
@article{Shen2026,
author = {Shen, Ying and Xiao, Yunlong and Liu, Lu and Zhai, Suzhen and Mu, Renwu and Chen, Jiahui and Yang, Xiaoyan and Wen, Xiaojun and Zhang, Chunlin and Shi, Hai},
title = {Dual-aptamer-activated RCA-MOF synergistic platform for visual detection of leukemia-derived exosomes},
journal = {Analytica Chimica Acta},
year = {2026},
doi = {10.1016/j.aca.2026.346094}
}
EUVIMED